Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

AstraZeneca team presents new P2X7 antagonists

Oct. 14, 2004

New NO-releasing COX inhibitors in early development at Altana

Oct. 14, 2004

Novel gastric antisecretory agents discovered at Altana

Oct. 14, 2004

Celltech researchers claim anti-IL-1beta antibodies and their use

Oct. 14, 2004

New p38 MAP kinase inhibitors and their use claimed by Pfizer

Oct. 13, 2004

New Nurr1 activators with potential utility in PD therapy

Oct. 13, 2004

Novel ALK4/ALK5 inhibitors discovered at Biogen Idec

Oct. 13, 2004

New androgen receptor antagonists in early development at Pfizer

Oct. 13, 2004

Two series of PTP inhibitors presented by TransTech researchers

Oct. 13, 2004

Novel chemokine CCR3 modulators and their use described by Boehringer Ingelheim

Oct. 13, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...